Search

Your search keyword '"Sanyal, Arun J."' showing total 1,792 results

Search Constraints

Start Over You searched for: Author "Sanyal, Arun J." Remove constraint Author: "Sanyal, Arun J." Language english Remove constraint Language: english
1,792 results on '"Sanyal, Arun J."'

Search Results

1. Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis

2. AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases

4. Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement

5. Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals

17. Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis

22. acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study

23. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

24. Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

25. Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study

29. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

30. aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

31. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

32. Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort

35. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals

37. Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

38. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

39. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis

45. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease

50. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores

Catalog

Books, media, physical & digital resources